Protein ISG15 Modification in the Development and the Treatment of Chronic Myeloid Leukemia

doi 10.21236/ada482354
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

The Role of Bosutinib in the Treatment of Chronic Myeloid Leukemia

Future Oncology
MedicineCancer ResearchOncology
2020English

Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Short Overview on the Current Treatment of Chronic Myeloid Leukemia in Chronic Phase

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Re-Emergence of Interferon-Α in the Treatment of Chronic Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia

Cancer
Cancer ResearchOncology
2010English

Chronic Myeloid Leukemia

2020English

Chronic Myeloid Leukemia

Hematologic Malignancies
2016English

Current Treatment Preferences in Chronic Myeloid Leukemia: The Mayo Clinic Physicians' Survey

American Journal of Hematology
Hematology
2017English

Development of Myasthenia Gravis in a Patient With Chronic Myeloid Leukemia During Treatment With Nilotinib

Hematology Reports
Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy